Patient Guide: AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 13 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06793371
Status: 🟢 Enrolling Now
Condition: Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF)
Phase: PHASE2

Where You Can Participate

This study is available at 13 locations across the country.

Top locations include:
  • • Fairhope, Alabama
  • • Pasadena, California
  • • Vista, California
  • • And 10 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF - Join Clinical Trial NCTNCT06793371

How to Join This Clinical Trial - NCTNCT06793371

Learn how to participate in this PHASE2 trial studying an investigational therapy for Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06793371 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 13 locations. Find a study site near you:

Clinical Research Site

Fairhope, Alabama 36532 - United States

Status: RECRUITING

Clinical Research Site

Pasadena, California 91105 - United States

Status: RECRUITING

Clinical Research Site

Vista, California 92081 - United States

Status: RECRUITING

Clinical Research Site

Hialeah, Florida 33016 - United States

Status: RECRUITING

Clinical Research Site

Peoria, Illinois 61636 - United States

Status: RECRUITING

Clinical Research Site

Rochester, Minnesota 55905 - United States

Status: RECRUITING

Clinical Research Site

St. Louis, Missouri 63110 - United States

Status: RECRUITING

Clinical Research Site

Morristown, New Jersey 07960 - United States

Status: RECRUITING

Clinical Research Site

Cincinnati, Ohio 45219 - United States

Status: RECRUITING

Clinical Research Site

Portland, Oregon 97239 - United States

Status: RECRUITING

And 3 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships